Otsuka Holdings Co Ltd (OTSKY)
20.63
+0.18
(+0.86%)
USD |
OTCM |
May 03, 16:00
Otsuka Holdings Price to Book Value: 1.349 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.349 |
| May 02, 2024 | 1.338 |
| May 01, 2024 | 1.350 |
| April 30, 2024 | 1.390 |
| April 29, 2024 | 1.350 |
| April 26, 2024 | 1.338 |
| April 25, 2024 | 1.310 |
| April 24, 2024 | 1.333 |
| April 23, 2024 | 1.345 |
| April 22, 2024 | 1.337 |
| April 19, 2024 | 1.321 |
| April 18, 2024 | 1.305 |
| April 17, 2024 | 1.320 |
| April 16, 2024 | 1.338 |
| April 15, 2024 | 1.333 |
| April 12, 2024 | 1.340 |
| April 11, 2024 | 1.344 |
| April 10, 2024 | 1.343 |
| April 09, 2024 | 1.340 |
| April 08, 2024 | 1.352 |
| April 05, 2024 | 1.343 |
| April 04, 2024 | 1.347 |
| April 03, 2024 | 1.376 |
| April 02, 2024 | 1.367 |
| April 01, 2024 | 1.369 |
| Date | Value |
|---|---|
| March 31, 2024 | |
| March 28, 2024 | 1.326 |
| March 27, 2024 | 1.347 |
| March 26, 2024 | 1.327 |
| March 25, 2024 | 1.331 |
| March 22, 2024 | 1.360 |
| March 21, 2024 | 1.352 |
| March 20, 2024 | 1.345 |
| March 19, 2024 | 1.339 |
| March 18, 2024 | 1.350 |
| March 15, 2024 | 1.299 |
| March 14, 2024 | 1.287 |
| March 13, 2024 | 1.293 |
| March 12, 2024 | 1.297 |
| March 11, 2024 | 1.30 |
| March 08, 2024 | 1.306 |
| March 07, 2024 | 1.290 |
| March 06, 2024 | 1.289 |
| March 05, 2024 | 1.285 |
| March 04, 2024 | 1.281 |
| March 01, 2024 | 1.289 |
| February 29, 2024 | 1.290 |
| February 28, 2024 | 1.300 |
| February 27, 2024 | 1.289 |
| February 26, 2024 | 1.244 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.924
Minimum
Mar 06 2023
1.558
Maximum
Dec 17 2019
1.231
Average
1.227
Median
May 28 2019
Price to Book Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 0.8775 |
| Nxera Pharma Co Ltd | 1.803 |
| PeptiDream Inc | 5.939 |
| Stemcell Holdings Inc | -- |
| Healios KK | 3.273 |
Price to Book Value Related Metrics
| PE Ratio | 23.35 |
| PS Ratio | 1.547 |
| Price to Free Cash Flow | 28.05 |
| Price | 20.63 |
| Earnings Yield | 4.28% |
| Market Cap | 22.39B |
| Operating PE Ratio | 10.57 |
| Normalized PE Ratio | 12.00 |